Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914062-13-000209
Filing Date
2013-07-03
Accepted
2013-07-03 12:27:59
Documents
1
Period of Report
2013-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4285
  Complete submission text file 0000914062-13-000209.txt   5715
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3204 BEVERLY DRIVE DALLAS TX 75205
Business Address
MAULDIN JOHN F (Reporting) CIK: 0001522480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 13952065